Skip to main content
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ARMP ISIN · US04216R1023 LEI · 549300QM1VCWH8KT0S21 US Manufacturing
Open in API
Filings indexed 1,011 across all filing types
Latest filing 2017-05-01 Earnings Release
Country US United States of America
Listing US ARMP

About Armata Pharmaceuticals, Inc.

https://www.armatapharma.com/

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing with the SEC, dated May 1, 2017, reporting the results of operations and financial condition, specifically announcing cash and cash equivalents as of March 31, 2017. The document includes a press release as an exhibit. The length is 3204 characters, which is relatively short and primarily serves as an announcement of financial results rather than a full financial report. It does not contain detailed financial statements or substantive financial data typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The content fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. Therefore, the appropriate classification is Earnings Release (ER).
2017-05-01 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC, dated May 1, 2017. It is a registration statement under the Securities Act of 1933, used for registering securities for public offering. The text includes details about the securities being registered, offering price, underwriting, risk factors, and other information typical of a registration statement prospectus. This is not a financial report, earnings release, or management discussion, but a regulatory filing related to capital raising. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual filing, not just an announcement or certification, so it fits CAP rather than RNS or RPA.
2017-05-01 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes detailed business and clinical trial information about AmpliPhi Biosciences Corporation, focusing on their biotechnology products and development pipeline. It does not contain financial statements or quarterly/yearly financial results, nor is it an earnings release or annual report. The document is not a proxy, voting result, or management change announcement. It is a regulatory filing providing an update on business developments and clinical progress, typical of an 8-K 'Other Events' report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2017-05-01 English
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans or employee stock purchase plans. The text includes details about the securities to be registered, the plans involved, and signatures of company officers. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Form S-8 filings are not among the specific categories like Annual Report, Earnings Release, or Capital Update, but fall under general regulatory filings. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is a full filing, not just an announcement or certification.
2017-05-01 English
FORM 8-K
Share Issue/Capital Change Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a one-for-ten reverse stock split and a proportional reduction in authorized shares, including the filing of Articles of Amendment to the Articles of Incorporation. This is a capital structure change event. The document does not contain financial statements or detailed financial analysis but announces a corporate action related to share capital. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is over 5,000 characters and contains substantive information about the capital change, not just an announcement of a report publication or a certification. Hence, the classification is SHA with high confidence.
2017-04-24 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes announcements of a reverse stock split, FDA feedback on a clinical trial, and exploration of strategic alternatives. There are no financial statements or detailed financial analysis present, only event disclosures. The document is not an annual or quarterly report, nor is it a transcript or presentation. It is a regulatory filing reporting significant corporate events. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is 7,711 characters, which is consistent with a detailed 8-K filing rather than a brief announcement or a full report.
2017-04-19 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.